JAK-IN-35
JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1].
Product Specifications
CAS Number
936091-15-5
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jak-in-35.html
Purity
99.30
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=CC(NC2=NC(NC3=CC=C(CN4CCOCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O
Molecular Formula
C26H34N6O3S
Molecular Weight
510.65
References & Citations
[1]Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx542319 96 Tests
Rat Rho-Related GTP-Binding Protein RhoB (RHOB) ELISA Kit
Sign In for Pricing
View Details 